-
3
-
-
0030704306
-
Prevalence of low femoral bone density in older US adults from NHANES III
-
Looker AC, Orwoll EX, Johnston CC Jr, et al. Prevalence of low femoral bone density in older US adults from NHANES III. J Bone Miner Res 1997;12:1761-1768.
-
(1997)
J Bone Miner Res
, vol.12
, pp. 1761-1768
-
-
Looker, A.C.1
Orwoll, E.X.2
Johnston C.C., Jr.3
-
4
-
-
0002349672
-
Osteoporosis: Review of the evidence for prevention, diagnosis and treatment and cost-effective analysis
-
National Osteoporosis Foundation. Osteoporosis: Review of the evidence for prevention, diagnosis and treatment and cost-effective analysis. Osteoporos Int 1998(suppl 4);S1-S88.
-
(1998)
Osteoporos Int
, Issue.SUPPL. 4
-
-
-
5
-
-
0029850615
-
Prevention and management of osteoporosis: Consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada
-
Hanley DA, Josse RG. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. Can Med Assoc J 1996;155(7):921-948.
-
(1996)
Can Med Assoc J
, vol.155
, Issue.7
, pp. 921-948
-
-
Hanley, D.A.1
Josse, R.G.2
-
6
-
-
0035253489
-
Effect of risedronate on the risk of hip fracture in elderly women
-
McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001;344(5):333-340.
-
(2001)
N Engl J Med
, vol.344
, Issue.5
, pp. 333-340
-
-
McClung, M.R.1
Geusens, P.2
Miller, P.D.3
-
7
-
-
0030840642
-
Modelling in economic evaluation: An unavoidable fact of life
-
Buxton MJ, Drummond MF, Van Hout BA, et al. Modelling in economic evaluation: An unavoidable fact of life. Health Econ 1997;6:217-222.
-
(1997)
Health Econ
, vol.6
, pp. 217-222
-
-
Buxton, M.J.1
Drummond, M.F.2
Van Hout, B.A.3
-
9
-
-
0027204989
-
Prevalence and incidence of vertebral deformities
-
Melton LJ III, Lane AW, Cooper C, et al. Prevalence and incidence of vertebral deformities. Osteoporos Int 1993;3:113-119.
-
(1993)
Osteoporos Int
, vol.3
, pp. 113-119
-
-
Melton L.J. III1
Lane, A.W.2
Cooper, C.3
-
10
-
-
0035178263
-
Challenges for model-based economic evaluations of postmenopansal osteoporosis interventions
-
Tosteson ANA, Jönsson B, Grima DT, et al. Challenges for model-based economic evaluations of postmenopansal osteoporosis interventions. Osteoporos Int 2001;12(10):849-857.
-
(2001)
Osteoporos Int
, vol.12
, Issue.10
, pp. 849-857
-
-
Tosteson, A.N.A.1
Jönsson, B.2
Grima, D.T.3
-
11
-
-
84992849681
-
Effectiveness and costs of osteoporosis screening and hormone replacement therapy
-
Washington DC: U.S. Government Printing Office
-
U.S. Office of Technology Assessment. Effectiveness and costs of osteoporosis screening and hormone replacement therapy. Vol II: Evidence on benefits, risks and costs. Washington DC: U.S. Government Printing Office, 1995.
-
(1995)
Evidence on benefits, risks and costs
, vol.2
-
-
-
12
-
-
0025153446
-
Cost effectiveness of screening perimenopausal white women for osteoporosis: Bone densitometry and hormone replacement therapy
-
Tosteson AN, Rosenthal DI, Melton LJ III, et al. Cost effectiveness of screening perimenopausal white women for osteoporosis: Bone densitometry and hormone replacement therapy. Ann Intern Med 1990;113(8):594-603.
-
(1990)
Ann Intern Med
, vol.113
, Issue.8
, pp. 594-603
-
-
Tosteson, A.N.1
Rosenthal, D.I.2
Melton L.J. III3
-
14
-
-
0027772390
-
Markov models in medical decision making: A practical guide
-
Sonnenberg F, Beck J. Markov models in medical decision making: A practical guide. Med Decis Making 1993;13:332-338.
-
(1993)
Med Decis Making
, vol.13
, pp. 332-338
-
-
Sonnenberg, F.1
Beck, J.2
-
16
-
-
0034069134
-
Risk of hip fracture derived from relative risks: An analysis applied to the population of Sweden
-
Kanis JA, Johnell O, Oden A, et al. Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden. Osteoporos Int 2000;11(2):120-127.
-
(2000)
Osteoporos Int
, vol.11
, Issue.2
, pp. 120-127
-
-
Kanis, J.A.1
Johnell, O.2
Oden, A.3
-
17
-
-
0028262189
-
Risk of hip fracture in women with vertebral fracture
-
Kotowicz MA, Melton LJ III, Cooper C, et al. Risk of hip fracture in women with vertebral fracture. J Bone Miner Res 1994;9(5):599-605.
-
(1994)
J Bone Miner Res
, vol.9
, Issue.5
, pp. 599-605
-
-
Kotowicz, M.A.1
Melton L.J. III2
Cooper, C.3
-
19
-
-
0031765564
-
Updated data on proximal femur bone mineral levels of US adults
-
Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 1998;8(5):468-489.
-
(1998)
Osteoporos Int
, vol.8
, Issue.5
, pp. 468-489
-
-
Looker, A.C.1
Wahner, H.W.2
Dunn, W.L.3
-
20
-
-
0004851872
-
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
-
Fracture Intervention Trial Research Group
-
Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996;348(9041): 1535-1541.
-
(1996)
Lancet
, vol.348
, Issue.9041
, pp. 1535-1541
-
-
Black, D.M.1
Cummings, S.R.2
Karpf, D.B.3
-
21
-
-
0027422191
-
Mortality and morbidity after hip fractures
-
Keene SK, Parker MJ, Pryor GA. Mortality and morbidity after hip fractures. BMJ 1993;307:1248-1250.
-
(1993)
BMJ
, vol.307
, pp. 1248-1250
-
-
Keene, S.K.1
Parker, M.J.2
Pryor, G.A.3
-
22
-
-
0031036671
-
Medical expenditures for the treatment ofosteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation
-
Ray NF, Chan JK, Thamer M, et al. Medical expenditures for the treatment ofosteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation. J Bone Miner Res 1997;12(1):24-35.
-
(1997)
J Bone Miner Res
, vol.12
, Issue.1
, pp. 24-35
-
-
Ray, N.F.1
Chan, J.K.2
Thamer, M.3
-
24
-
-
0027510403
-
The Beaver Dam Health Outcomes Study: Initial catalog of health-state quality factors
-
Fryback DG, Dasbach EJ, Klein R, et al. The Beaver Dam Health Outcomes Study: Initial catalog of health-state quality factors. Med Decis Making 1993; 13(2):89-102.
-
(1993)
Med Decis Making
, vol.13
, Issue.2
, pp. 89-102
-
-
Fryback, D.G.1
Dasbach, E.J.2
Klein, R.3
-
25
-
-
0035698323
-
Impact of hip and vertebral fractures on quality-adjusted life years
-
Tosteson ANA, Gabriel SE, Grove MR, et al. Impact of hip and vertebral fractures on quality-adjusted life years. Osteoporos Int 2001;12:1042-1049.
-
(2001)
Osteoporos Int
, vol.12
, pp. 1042-1049
-
-
Tosteson, A.N.A.1
Gabriel, S.E.2
Grove, M.R.3
-
26
-
-
0031777481
-
Targeting high-risk populations
-
Jönsson B. Targeting high-risk populations. Osteoporos Int 1998(suppl 1);S13-S16.
-
(1998)
Osteoporos Int
, Issue.SUPPL. 1
-
-
Jönsson, B.1
-
27
-
-
0027204989
-
Prevalence and incidence of vertebral deformities
-
Melton LJ III, Lane AW, Cooper C, et al. Prevalence and incidence of vertebral deformities. Osteoporos Int 1993;3(3):113-119.
-
(1993)
Osteoporos Int
, vol.3
, Issue.3
, pp. 113-119
-
-
Melton L.J. III1
Lane, A.W.2
Cooper, C.3
-
28
-
-
12944291524
-
Randomized trial of the effects of risedronate on vertebral fractures in women with established post-menopausal osteoporosis
-
Vertebral Efficacy with Risedronate Therapy (VERT) Study Group
-
Reginster J, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established post-menopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 2000;11(1):83-91.
-
(2000)
Osteoporos Int
, vol.11
, Issue.1
, pp. 83-91
-
-
Reginster, J.1
Minne, H.W.2
Sorensen, O.H.3
-
29
-
-
0026611268
-
Targeted estrogen/progestogen replacement therapy for osteoporosis: Calculation of health care cost savings
-
Clark AP and Schuttinga JA. Targeted estrogen/progestogen replacement therapy for osteoporosis: Calculation of health care cost savings. Osteoporos Int 1992;2:195-200.
-
(1992)
Osteoporos Int
, vol.2
, pp. 195-200
-
-
Clark, A.P.1
Schuttinga, J.A.2
-
30
-
-
0010342640
-
Hospital costs, days, and post-acute care for vertebral fractures in women
-
Burge RT, Worley DJ. Hospital costs, days, and post-acute care for vertebral fractures in women. Value in Health 2000;3(5):336.
-
(2000)
Value in Health
, vol.3
, Issue.5
, pp. 336
-
-
Burge, R.T.1
Worley, D.J.2
-
31
-
-
0028245442
-
Costs and health effects of osteoporotic fractures
-
Chrischilles E, Shireman T, Wallace R. Costs and health effects of osteoporotic fractures. Bone 1994;15(4):377-386.
-
(1994)
Bone
, vol.15
, Issue.4
, pp. 377-386
-
-
Chrischilles, E.1
Shireman, T.2
Wallace, R.3
-
32
-
-
0023788185
-
The direct medical costs of osteoporosis for American women aged 45 and older, 1986
-
Phillips S, Fox N, Jacobs J, et al. The direct medical costs of osteoporosis for American women aged 45 and older, 1986. Bone 1988;9:271-279.
-
(1988)
Bone
, vol.9
, pp. 271-279
-
-
Phillips, S.1
Fox, N.2
Jacobs, J.3
-
33
-
-
0003469046
-
-
New York: Oxford University Press
-
Gold, MR, Siegel, JE, Russell, LB, et al. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
-
(1996)
Cost-Effectiveness in Health and Medicine
-
-
Gold, M.R.1
Siegel, J.E.2
Russell, L.B.3
-
34
-
-
0028929689
-
Cost-effectiveness of fracture prevention in established osteoporosis
-
Jönsson B, Christiansen C, Johnell O, et al. Cost-effectiveness of fracture prevention in established osteoporosis. Osteoporos Int 1995;5:136-142.
-
(1995)
Osteoporos Int
, vol.5
, pp. 136-142
-
-
Jönsson, B.1
Christiansen, C.2
Johnell, O.3
-
35
-
-
0000928679
-
Alendronate use among 812 women: Prevalence of gastrointestinal complaints, noncompliance with patient instructions, and discontinuation
-
Ettinger B, Pressman A, Schein J, et al. Alendronate use among 812 women: Prevalence of gastrointestinal complaints, noncompliance with patient instructions, and discontinuation. J Manag Care Pharmacy 1998;4(5):488-492.
-
(1998)
J Manag Care Pharmacy
, vol.4
, Issue.5
, pp. 488-492
-
-
Ettinger, B.1
Pressman, A.2
Schein, J.3
-
36
-
-
0031733852
-
Clinic visits and hospital admissions for care of acid-related upper gastrointestinal disorders in women using alendronate for osteoporosis
-
Ettinger B, Pressman A, Schein J. Clinic visits and hospital admissions for care of acid-related upper gastrointestinal disorders in women using alendronate for osteoporosis. Am J Manag Care 1998;4(10):1377-1382.
-
(1998)
Am J Manag Care
, vol.4
, Issue.10
, pp. 1377-1382
-
-
Ettinger, B.1
Pressman, A.2
Schein, J.3
-
37
-
-
0010343157
-
-
First DataBank, Inc, San Bruno, CA. January 8
-
National Drug Data File. First DataBank, Inc, San Bruno, CA. January 8, 2001.
-
(2001)
National Drug Data File
-
-
|